Berenberg Bank Raises Lam Research (NASDAQ:LRCX) Price Target to $335.00

23 Apr 2026, 11:06 by Jessica Moore · The Cerbat Gem

Lam Research (NASDAQ:LRCX – Get Free Report) had its target price raised by equities research analysts at Berenberg Bank from $265.00 to $335.00 in a research report issued on Thursday,MarketScreener reports. The brokerage currently has a “buy” rating on the semiconductor company’s stock. Berenberg Bank’s price objective suggests a potential upside of 26.51% from the stock’s current price.

A number of other analysts also recently commented on LRCX. The Goldman Sachs Group reaffirmed a “buy” rating on shares of Lam Research in a research report on Thursday. Bank of America lifted their target price on Lam Research from $195.00 to $245.00 and gave the company a “buy” rating in a report on Tuesday, January 13th. Citigroup restated a “buy” rating on shares of Lam Research in a research report on Thursday. Mizuho set a $265.00 price target on shares of Lam Research in a report on Wednesday, January 28th. Finally, Stifel Nicolaus upped their price target on shares of Lam Research from $280.00 to $300.00 and gave the stock a “buy” rating in a report on Monday, April 13th. Twenty-seven equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $272.73.

Check Out Our Latest Analysis on LRCX

Lam Research Trading Down 0.3%

Shares of Lam Research stock opened at $264.79 on Thursday. The company has a market capitalization of $330.67 billion, a P/E ratio of 54.26, a price-to-earnings-growth ratio of 2.75 and a beta of 1.78. The stock has a fifty day simple moving average of $233.80 and a 200 day simple moving average of $196.58. Lam Research has a 12-month low of $67.55 and a 12-month high of $273.50. The company has a current ratio of 2.26, a quick ratio of 1.61 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX – Get Free Report) last posted its quarterly earnings data on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.11. The firm had revenue of $5.84 billion for the quarter, compared to the consensus estimate of $5.70 billion. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The business’s revenue for the quarter was up 23.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.04 EPS. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. On average, sell-side analysts anticipate that Lam Research will post 5.3 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Lam Research news, insider Ava Harter sold 4,000 shares of the company’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $232.50, for a total transaction of $930,000.00. Following the completion of the sale, the insider directly owned 54,705 shares in the company, valued at $12,718,912.50. This represents a 6.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Douglas R. Bettinger sold 50,057 shares of Lam Research stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $224.03, for a total value of $11,214,269.71. Following the completion of the transaction, the chief financial officer owned 1,081,705 shares in the company, valued at approximately $242,334,371.15. This represents a 4.42% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 130,886 shares of company stock worth $29,658,802 in the last 90 days. 0.31% of the stock is owned by company insiders.

Institutional Trading of Lam Research

Large investors have recently modified their holdings of the business. PMV Capital Advisers LLC purchased a new position in Lam Research during the 4th quarter valued at $25,000. Stance Capital LLC purchased a new position in shares of Lam Research during the third quarter valued at about $26,000. Bayban bought a new position in Lam Research in the fourth quarter worth about $26,000. Vermillion Wealth Management Inc. purchased a new stake in Lam Research in the first quarter worth about $26,000. Finally, Triumph Capital Management bought a new stake in Lam Research during the 3rd quarter valued at approximately $27,000. 84.61% of the stock is owned by institutional investors.

Key Headlines Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

Positive Sentiment: Lam reported fiscal Q3 results above estimates — $1.47 non-GAAP EPS vs. $1.36 consensus and $5.84B revenue (up 23.8% YoY). The release highlights record revenue and improved margins that underpinned the rally. PR Newswire
Positive Sentiment: Management raised FYQ4 guidance: EPS $1.50–1.80 and revenue guidance midpoint (~$6.6B) came in above street expectations, signaling continued WFE strength. That upside to guidance is a primary driver of the rally. MarketBeat — Earnings
Positive Sentiment: AI-driven chip demand is cited repeatedly as the demand engine — analysts and press note expanding spending on AI logic and memory fabs is lifting orders and margins for Lam’s etch/dep tools. Globe and Mail — Deep Dive
Positive Sentiment: Wall Street raised targets and reiterated buys after the beat — examples include Needham ($300), BofA ($330) and TD Cowen ($340) — adding momentum as analysts push valuation higher. TipRanks — Ratings
Neutral Sentiment: The company’s earnings call transcript and slide deck are available for investors digging into product-level demand, backlog and capex cadence. Seeking Alpha — Call Transcript
Neutral Sentiment: Lam is named as a supplier for large-scale projects (e.g., Tesla Terafab), which supports long-duration revenue potential but requires execution and timelines to play out. Barchart — Terafab
Negative Sentiment: Some commentators warn LRCX faces an earnings “test” after a sharp pre-report rally; elevated valuation metrics (P/E >50) mean expectations are high and leave limited room for disappointment. Seeking Alpha — Caution

About Lam Research

(Get Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.